Abstract
ABSTRACT. Unprecedented in human history the problem of coronavirus infection, caused by the SARS-CoV-2 virus, raised a huge amount of fundamental issues regarding the pathogenesis of the COVID-19, the interaction of the virus with the pulmonary microbioma and the immune system of human. The impact on the course of other diseases, including the tuberculosis process, remains the main theme of modernity. Among the priority areas are further search and improvement of the diagnosis of immuno-mediated disorders in patients with pulmonary tuberculosis caused by coronavirus infection, by identifying the most rational diagnostic tests of these disorders.
Publisher
Communicable Diseases Intensive Care Association
Reference42 articles.
1. Todoriko L.D., Feshchenko Yu.I., Semianiv I.O., et al. Aspects of coronavirus infection pathogenesis and prognosis for pathomorphosis of pulmonary tuberculosis during the COVID-19 pandemic. Ukr. Pulmonol. Journ. 2022; 2-3: 12-22. DOI: 10.31215/2306-4927-2022-30-2-12-22.
2. Rekalova O.M. COVID-19-associated changes of immunity and lesions of the lungs. Ukr. Pulmonol. Journ. 2023; 2: 13-23. DOI: 10.31215/2306-4927-2023-31-2-13-23.
3. WHO Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic. WHO, 2021. Available at: https://www.who.int/ru/news/item/14-10-2021-tuberculosisdeaths-rise-for-the-first-time-in-more-thana-decade-due-tothe-covid-19-pandemic.
4. Valetskyi Yu.M., Valetska R.O., Hryshchuk L.A., et al. Tuberculosis in Ukraine during the COVID-19 pandemic. Tuberculosis, Lung Diseases, HIV Infection. 2022; 4: 45-50. DOI: 10.30978/TB-2022-4-45.
5. Aggarwal A.N., Agarwal R., Dhooria S., et al. Active pulmonary tuberculosis and coronavirus disease 2019: a systematic review and meta-analysis. PloS One. 2021; 16: e0259006. DOI: 10.1371/journal.pone.0259006.